BICO News Feed

Discover the latest news from our business areas.

Biosero takes home the 2022 Sammy Award for their Acceleration Lab

Share on facebook
Share on twitter
Share on linkedin

“Building the Acceleration Lab represented a major investment for Biosero, and it has become a tremendous asset for our team in delivering custom-tailored demonstrations, offering virtual tours for those who can’t come in person, and testing new products. The Acceleration Lab allows users to see their automation ideas come to life, and we are honored that it was recognized with a Sammy award.”  – Tom Gilman, CEO of Biosero. 

Biosero, Inc., a BICO company and developer of laboratory automation solutions to orchestrate scientific discoveries, announced that Its Acceleration Lab has been named a winner of the 2022 Sales and Marketing Technology Awards from the Business Intelligence Group. The awards, known as the Sammys, honor organizations and products helping to solve the challenges organizations have connecting and collaborating with prospects and customers.

 

Biosero’s Acceleration Lab was named Product of the Year for a company with fewer than 100 employees. The San Diego-based lab is a proving ground for lab automation technology, offering a real-world laboratory environment where prospective customers can see how Biosero’s automation software works with the kinds of instruments and workflows they use. Lab tours showcase tough-to-explain concepts such as remote management, mobile robotics, multi-workcell integration, low-code/no-code workflow design, data integration, environment monitoring, and order management.

 

“Building the Acceleration Lab represented a major investment for Biosero, and it has become a tremendous asset for our team in delivering custom-tailored demonstrations, offering virtual tours for those who can’t come in person, and testing new products,” said Tom Gilman, CEO of Biosero. “The Acceleration Lab allows users to see their automation ideas come to life, and we are honored that it was recognized with a Sammy award.”

 

The Business Intelligence Group’s awards are judged by business executives with experience and knowledge, and a unique scoring system is used to selectively measure performance across multiple business domains and reward the companies whose achievements stand out from their peers.

 

“We are proud to reward and recognize Biosero for their innovation and dedication to helping both the organization using their technology and the ultimate consumer,” said Maria Jimenez, Chief Nominations Officer, Business Intelligence Group. “It was clear to our judges that their efforts will improve how we all connect with the brands we love for years to come.”

Since its launch in 2019, the Biosero Acceleration Lab has received hundreds of visitors, with new virtual and in-person tours scheduled regularly. Biosero is now building Acceleration Labs in Japan, Germany, and Boston to make automation strategy tools more accessible to these scientific communities.

 

More news

August 8, 2022 | Cytena

CYTENA launches new generation of B.SIGHT, a fully automated single-cell dispenser for microorganisms

July 28, 2022 | Scienion

SCIENION announces expansion in the UK with the opening of new R&D and manufacturing facilities

July 26, 2022 | Bico

Biosero takes home the 2022 Sammy Award for their Acceleration Lab

July 12, 2022 | Cytena

CYTENA BPS launches C.NEST – a robust, flexible & reliable microbioreactor

July 11, 2022 | Dispendix

We are the champions!

July 10, 2022 | Cytena

B2Run Freiburg 2022

July 8, 2022 | Bico

Multiplex tests to detect pathogens and toxins in public water supply

July 8, 2022 | Bico

Precise and sensitive tools for COVID-19 monitoring

July 5, 2022 | Scienion

Highfield Diagnostics and SCIENION Sign Memorandum of Understanding

July 4, 2022 | Cellink

CELLINK has entered a collaboration agreement with Spermosens AB, Malmö University and SLU to develop an invitro diagnostic (IVD) device that helps determine infertility.

June 6, 2022 | Cellink

Bioprinted Ear Successfully Transplanted into Patient

June 1, 2022 | Dispendix

ESHG & ISSCR 2022

June 1, 2022 | Scienion

SCIENION bestellt Frauke Hein als CEO

May 30, 2022 | Dispendix

BICO Management Summit 2022

May 24, 2022 | Cellenion

Breakfast with Cellenion

May 6, 2022 | Cellenion

cellenONE Training & Workshop – June 2022

May 6, 2022 | Cellink

BICO acquires Allegro 3D, adding new light-based 3D bioprinting technology

March 3, 2022 | Cellenion

Cellenion Announces Opening of BICO’s First Single Cell Analysis Centre of Excellence